4/A: Iradimed CFO Corrects Stock Disposal Error in Amended SEC Filing

John Glenn, CFO of Iradimed, files an amended Form 4 to correct a previous error regarding the disposal of 5,796 Restricted Stock Units (RSUs).

Summary

• John Glenn, the CFO of Iradimed Corporation, filed an amended Form 4 with the SEC.
• The amendment corrects an error in the original Form 4 filed on April 4, 2025.
• The original filing incorrectly stated that Mr. Glenn acquired 5,796 Restricted Stock Units (RSUs).
• The corrected filing clarifies that Mr. Glenn disposed of 5,796 RSUs.
• The disposal occurred on June 20, 2024.
• Mr. Glenn still beneficially owns 11,592 shares of Iradimed common stock directly.
• The RSUs were granted under Iradimed Corporation's 2014 Equity Incentive Plan and vest in four equal annual installments beginning on June 20, 2023.

Sentiment

Score: 6

Explanation: The document is a routine correction of a filing error. While the error itself is a negative, the correction is a positive. Overall, the impact is neutral.

Negatives

• The original Form 4 contained an error, requiring an amendment.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.

Stakeholder Impact

• The correction ensures accurate information is available to shareholders regarding executive stock ownership.

Key Dates

Keywords

Form 4, IRMD, Iradimed, CFO, John Glenn, Restricted Stock Units, RSUs, SEC Filing, Disposal, Amendment